Lobbying Law Should Not Deter Researchers From Speaking Out On Behalf Of Science

From Speaking Out On Behalf Of Science At the end of 1995, the United States Congress enacted a new lobbying law, replacing a hodgepodge of vague disclosure requirements adopted over the previous 40 years. The intent of the new law is to provide the public with an accurate listing of the people and organizations involved in lobbying and a general accounting of funds expended on such activities. As research institutions consider their responsibilities under the new law, faculty and administrato

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

From Speaking Out On Behalf Of Science April Burke At the end of 1995, the United States Congress enacted a new lobbying law, replacing a hodgepodge of vague disclosure requirements adopted over the previous 40 years. The intent of the new law is to provide the public with an accurate listing of the people and organizations involved in lobbying and a general accounting of funds expended on such activities. As research institutions consider their responsibilities under the new law, faculty and administrators may become concerned that their interactions with Congress and executive branch agencies "brand" them as lobbyists.

But this is a time when scientists need to be science advocates, resisting the inference that the Lobbying Disclosure Act is a deterrent to communicating with policy-makers about the federal science investment. Although broader than the old law, the new legislation is not intended to "catch" people who occasionally make their views known about ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • April Burk

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo